The Technical AnalystExchange: STO Sector: Healthcare Industry: Medical Care Facilities
Medicover AB (publ) Price, Forecast, Insider, Ratings, Fundamentals & Signals
-0.81% SEK195.20
America/New_York / 17 mai 2024 @ 11:29
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 29 212 mill |
| EPS: | 1.740 |
| P/E: | 112.18 |
| Earnings Date: | Jul 25, 2024 |
| SharesOutstanding: | 149.65 mill |
| Avg Daily Volume: | 0.138 mill |
| RATING 2024-05-17 |
|---|
| A+ |
| Strong Buy |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Buy | |
| Return On Equity: | Neutral | |
| Return On Asset: | Buy | |
| DE: | Strong Buy | |
| P/E: | Strong Buy | |
| Price To Book: | Buy |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | 1/24 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | n/a | |||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 5.68x |
| Company: PE 112.18 | sector: PE 19.76 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 1.77x |
| Company: PE 112.18 | industry: PE 63.35 |
| DISCOUNTED CASH FLOW VALUE |
|---|
|
SEK150.12 (-23.09%) SEK-45.08 |
| Date: 2024-05-18 |
| Expected Trading Range (DAY) |
|---|
|
SEK 191.47 - 198.93 ( +/- 1.91%) |
| ATR Model: 14 days |
Live Trading Signals (every 1 min)
10.00
Buy
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | SEK195.20 (-0.81% ) |
| Volume | 0.0667 mill |
| Avg. Vol. | 0.138 mill |
| % of Avg. Vol | 48.51 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For MCOV-B.ST
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
MCOV-B.ST
Medicover AB (publ) provides healthcare and diagnostic services in Germany, Sweden, Poland, Turkey, Belarus, Bulgaria, Georgia, Hungary, Serbia, Moldova, Ukraine, and India. It operates through two segment, Healthcare Services and Diagnostic Services. The company's diagnostic services comprise various tests, including allergy and autoimmune diagnostics, bacteriology, parasitology, biochemistry and immunochemistry, blood group diagnostics/transfusion medicine, tumour markers, clinical chemistry, cytology, haematology, histopathology, human genetics, hygiene, immunology and immunochemistry, infectious diseases, microbiology, molecular biology, and pharmacology/toxicology. The company operates 97 clinical laboratories, 733 blood-drawing points, and 26 clinics in 10 countries; and 117 medical clinics, 20 fertility clinics, 52 dental clinics, 25 hospitals, and 25 gyms. It serves corporate and private customers, and patients, as well as public payers. Medicover AB (publ) was founded in 1995 and is headquartered in Stockholm, Sweden.